Duopharma net profit rises 15% in 1Q

Duopharma Biotech group managing director Leonard Ariff Abdul Shatar

KUALA LUMPUR: Duopharma Biotech Bhd’s net profit rose 15.2% to RM20.29mil in the first quarter ended March 31 against RM17.61mil a year ago on higher sales.

The pharmaceutical group saw its revenue rise 11.7% to RM185.94mil from RM166.45mil a year prior. Its earnings per share for the quarter stood at 2.19 sen, compared with 1.90 sen last year.

Duopharma group managing director Leonard Ariff Abdul Shatar said earnings in the upcoming quarters will be buoyed by the RM375mil revised Government tender to supply Insugen-Insulin Recombinant Human Formulations.

In addition, the contract to supply pharmaceutical and non-pharmaceutical products to government hospitals and clinics has been extended for 12 months until end-2022.

Duopharma may also enjoy potential savings of more than RM10mil upon the completion of some qualifying assets by 2024, following the Budget 2022 announcement that the period for special reinvestment allowance will be extended to the year of assessment 2024.

“We are cautiously optimistic with our outlook this year as the country’s economy is improving following the reopening of borders and with most Covid-19 restrictions having been lifted.

“Over the longer term, demand for healthcare services is growing and the government’s continuous emphasis on the sector will bode well for the company,” Leonard Ariff said.

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 46
Cxense type: free
User access status: 3
Join our Telegram channel to get our Evening Alerts and breaking news highlights

Next In Business News

Idimension exits GN3 status after regularisation completes
TNB issues Sukuk Wakalah worth RM4bil
Reach Energy to undertakeRM206.51mil debt via issuance of 1.03 billion new shares
Mudajaya to acquire Real Jade for RM224.32mil
MPOB issues letter of reminder after palm oil manufacturers stop ops
Farm Fresh buys industrial land for RM18.24m to build manufacturing hub
Qhazanah Sabah inks MoU with Berjaya Land for study on KK airport move to Kimanis
Public Mutual declares RM114mil distributions for 11 funds
PetChem inks MoU with AFES
RM1.2bil Kampung Bharu redevelopment project gets residents' green light

Others Also Read